[{"name": "囊膜病毒与结构免疫学研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "gaof@im.ac.cn", "job_title": "院士", "abstracts": "高福主要从事病原微生物跨宿主传播、感染机制与宿主细胞免疫研究以及公共卫生政策与全球健康策略研究。领导的研究组在流感病毒流行病学、跨种传播分子机制研究领域建树颇多，首次证实野生迁徙鸟能够群体感染高致病性H5N1禽流感病毒，改变了野生迁徙鸟只是流感病毒贮存宿主的结论；发现H7N9禽流感病毒是一种新型的重配病毒，与长江三角地区迁徙鸟和家禽有关，呼吁关闭活禽市场以预防病毒的进一步传播和可能的全球大流行，为国家制定禽流感防控政策提供了重要基础。率领首批中国疾病预防控制中心移动实验室检测队赴塞拉利昂抗击埃博拉，描绘出埃博拉病毒的进化图，在抗击埃博拉病毒的国际援助行动中发挥了关键作用。对流感病毒、埃博拉、MERS-CoV和寨卡等多种囊膜病毒的入侵机制进行研究，阐明其分子机制，并研发抗体、药物等抗病毒手段，为新发突发传染病防控提供重要支撑。率领团队率先确认新冠病毒全基因组序列并分离病毒，确定传播途径和源头等流行病学重要参数以及疫苗研发。领导中国疾控中心为成功控制新冠疫情流行提供了重要支撑，加强与发达国家及非洲等的合作。", "directions": "流感等囊膜病毒与宿主的相互作用\nT细胞免疫与分子识别\n新发、再发传染病\n公共卫生政策与全球健康策略的研究", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": null, "award": "求是杰出科技成就集体奖 （2019）\n香港大学百周年杰出中国学者（2019）\n俄罗斯“Gamaleya奖章”（2018）\n第十届健康中国总评榜年度人物（健康报）（2018）\n国家科学技术进步奖特等奖（2017，排名7）\n全国创新争先奖（2017）\n2016中国生命科学领域十大进展（中国科协生命科学学会联合体）（2016）\n2016中国医学科技十大新闻（健康报）（2016）\n2016中国科学年度新闻人物（中国科学报）（2016）\n第三届树兰医学奖（2016）\n全国杰出科技人才奖（2016）\n日本外务大臣表彰奖（2015）\n吴阶平-保罗·杨森医学药学奖（简称吴杨奖）（2015）\n何梁何利基金科学与技术进步奖（2015）\n2015中国科学十大进展（科技部、中国科学院、中国工程院、中国科学报）（2015）\n中华医学科技奖一等奖（2011，排名2；2015，排名12）\n中华预防医学会科学技术奖一等奖（2011，排名2；2015，排名12；2017，排名1）\n国家科学技术进步奖一等奖（2014，排名12）和二等奖（2011，排名4；2014，排名2）\n中国科学院杰出科技成就奖（2014）\n第19届日本日经亚洲奖（Nikkei Asia Prize）（2014）\n第7届（2014）谈家桢生命科学成就奖和首届（2008）谈家桢生命科学创新奖\n2013中国科学十大进展（科技部、中国科学院、中国工程院、中国科学报）（2013）\n2013十大科技创新人物（中央电视台与中国科学院、中国工程院）（2013）\n发展中国家科学院（TWAS）基础医学奖（2012）\n北京市科学技术奖一等奖（2011）\n中国科学技术协会首届青年科技奖（1988）", "paper": "1. Li, L., Liao, H., Meng, Y., Li, W., Han, P., Liu, K., Wang, Q., Li, D., Zhang, Y., Wang, L., Fan, Z., Zhang, Y., Wang, Q., Zhao*, X., Sun*, Y., Huang*, N., Qi*, J. and Gao*, G. F., 2022, Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1. Cell, 185 (16): 2952-2960.e10.\n2. Xu, K., Gao, P., Liu, S., Lu, S., Lei, W., Zheng, T., Liu, X., Xie, Y., Zhao, Z., Guo, S., Tang, C., Yang, Y., Yu, W., Wang, J., Zhou, Y., Huang, Q., Liu, C., An, Y., Zhang, R., Han, Y., Duan, M., Wang, S., Yang, C., Wu, C., Liu, X., She, G., Liu, Y., Zhao, X., Xu, K., Qi, J., Wu*, G., Peng*, X., Dai*, L., Wang*, P. and Gao*, G. F., 2022, Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2. Cell, 185 (13): 2265-2278.e14.\n3. Han, P., Li, L., Liu, S., Wang, Q., Zhang, D., Xu, Z., Han, P., Li, X., Peng, Q., Su, C., Huang, B., Li, D., Zhang, R., Tian, M., Fu, L., Gao, Y., Zhao, X., Liu, K., Qi*, J., Gao*, G. F. and Wang*, P., 2022, Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell, 185 (4): 630-640.e10.\n4. Liu, K., Pan, X., Li, L., Yu, F., Zheng, A., Du, P., Han, P., Meng, Y., Zhang, Y., Wu, L., Chen, Q., Song, C., Jia, Y., Niu, S., Lu, D., Qiao, C., Chen, Z., Ma, D., Ma, X., Tan, S., Zhao, X., Qi*, J., Gao*, G. F. and Wang*, Q., 2021, Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell, 184 (13): 3438-3451.e10.\n5. Wang, H., Zhang, Y., Huang, B., Deng, W., Quan, Y., Wang, W., Xu, W., Zhao, Y., Li, N., Zhang, J., Liang, H., Bao, L., Xu, Y., Ding, L., Zhou, W., Gao, H., Liu, J., Niu, P., Zhao, L., Zhen, W., Fu, H., Yu, S., Zhang, Z., Xu, G., Li*, C., Lou*, Z., Xu*, M., Qin*, C., Wu*, G., Gao*, G. F., Tan*, W. and Yang*, X., 2020, Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell, 182 (3): 713-721.e9.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202101/W020210120429270501575.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究组长", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202101/t20210120_5873142.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "病毒感染及生物制药研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": null, "job_title": "研究员", "abstracts": "刘文军，英文名: Wenjun (Frank) Liu博士，研究员，博士生导师。教育经历（按时间倒序排序）：1991/5 - 1996/5，美国佛罗里达大学，分子和细胞生物学，博士1982/8 - 1985/8，北京农业大学，动物组织胚胎学，硕士1978/3 - 1982/8，北京农业大学，兽医，学士", "directions": "病毒与宿主细胞相互作用\n动物病毒分子进化\n新型免疫增强剂和抗病毒药物", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "1. 利用CRISPR-Cas9系统构建的敲除IFN-β基因的293T细胞系\n2. 一种鸭病毒性肝炎的灭活疫苗及其制备方法与应用\n3. 一种检测禽流感病毒的表面增强拉曼光谱基底物及其应用\n4. 用于鉴定军团菌毒力的方法\n5. ISG20蛋白及其编码基因在抗流感病毒中的应用\n6. 一种用于预防猪口蹄疫的干扰素白油组合物\n7. 导入特异shRNA得到的CypA基因被沉默的重组哺乳动物细胞\n8. 一种猪肺特异性启动子及其应用\n9. 流感病毒M1蛋白及其编码基因和应用\n10. 针对鸡新城疫病毒、禽流感病毒和鸡传染性支气管炎病毒的三联卵黄抗体\n11. CypA蛋白片段及其在制备抗炎症药物中的应用\n12. 鸡源热休克蛋白及其编码基因和应用\n13. 抑制A型流感病毒M1蛋白发生磷酸化的方法及其应用\n14. 利用毕赤酵母生产猪Gp96蛋白的方法及专用培养基\n15. 检测I型鸭肝炎病毒的环介导等温扩增试剂盒及应用\n16. 一种动物呼吸道特异性启动子及其应用\n17. 特异多肽在制备狂犬病疫苗中的应用\n18. 多肽片段组合物及其在制备猪繁殖与呼吸综合征疫苗中的应用\n19. 一株鸡源H9N2禽流感病毒毒株及其应用\n20. 优化的草鱼α干扰素编码基因及其应用\n21. 预防鸭病毒性肝炎的灭活疫苗及其制备方法\n22. 辅助鉴定猪链球菌2型与猪链球菌7型的专用引物及其应用\n23. 预防鸭病毒性肝炎的灭活疫苗及其制备方法\n24. 编码鸡α干扰素的优化基因及其在制备鸡α干扰素中的应用\n25. 猪用抗原呈递蛋白及其编码基因和应用\n26. 一种预防猪生殖与呼吸综合征的疫苗\n27. 一种检测狂犬病病毒的酶联免疫试剂盒\n28. 一种猫α干扰素及其编码基因与其应用\n29. 一种改良重组猪α干扰素蛋白及其编码基因与应用\n30. 猪γ干扰素及其编码基因与应用\n31. 猫ω干扰素及其编码基因与应用", "project": "承担了国家自然科学基金重点、面上项目，科技部国家重点研发计划，卫生部重大传染病防治专项，中国科学院重点部署项目等。", "award": null, "paper": "1. W-J Chai#, J Li#, Q Shangguan, Q Liu, X-D Li, D-D Qi, X-M Tong, W-J Liu, X Ye*. 2018. Lnc-ISG20 inhibits influenza A virus replication by enhancing ISG20 expression. Journal of Virology.\n2. J Li, K Zhang, Q-Y Chen, X Zhang, Y-P Sun, Y-H Bi, S Zhang, J-Y Gu, J-R Li, Di Liu, W-J Liu*, J-Y Zhou*. 2018. Three Amino Acid Substitutions in the NS1 Protein change the Virus Replication of H5N1 Influenza Virus in Human Cells. Virology.\n3. Y Li, L Sun*, W-N Zheng, Madina·M, J Li, Y-H Bi, H Wang, W-J Liu*, Luo T*. 2018. Phosphorylation and dephosphorylation of threonine 188 innucleoprotein is crucial for the replication of influenza A virus. Virology.\n4. C Chen, W-H Fan, J Li, W-N Zheng, S Zhang, L-Y Yang, D Liu, W-J Liu*, L Sun*. 2018. A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus. Front. Cell. Infect. Microbiol.\n5. Y-P Sun, J-W Jiang, P Tien, W-J Liu*, J Li*. 2018. IFN-λ: A new spotlight in innate immunity against influenza virus infection. Protein & Cell.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/W020181109586880228564.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员", "office_address": null, "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/t20181109_5168617.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "病原菌致病及耐药机理研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806197", "email": "liucuihua@im.ac.cn", "job_title": "博士、研究员", "abstracts": "刘翠华博士，研究员，研究组长。主要研究方向为病原菌与宿主互作的分子机制及病原菌抗生素耐药和耐受的分子机制。", "directions": "1. 重要病原菌与宿主互作的分子机制\n2. 重要病原菌抗生素耐药和耐受的分子机制", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "1. 刘翠华，柴琪瑶，汪静；一种重组卡介苗的构建与应用；申请号：202210425903.9\n2. 刘翠华，汪静；结核病患者特异性高表达NK细胞受体及其应用；申请号：202111026159.7\n3. 刘翠华，张勇，汪静；一种抗结核分枝杆菌入侵细胞的靶点及其应用；申请号：202110518930.6\n4. 汪静，刘翠华；一种治疗结核病的药物；申请号：202110367728.8\n5. 刘翠华，汪静；一种肠易激综合征小鼠模型及其应用；申请号：202010430662.8\n6. 刘翠华，柴琪瑶，陆喆，汪静；肺结节诊断标志物及应用；申请号：202010350286.1\n7. 刘翠华，柴琪瑶，陆喆，汪静；肺结核标志物及应用；授权号：ZL202010349875.8\n8. 刘翠华，汪静；一种抗结核分枝杆菌的靶点及其应用；授权号：ZL201811430799.2\n9. 刘翠华，汪静；一种抗结核分枝杆菌的靶点及其应用；授权号：ZL 201811430645.3\n10. 刘翠华，汪静；一种抗结核分枝杆菌的靶点及其应用；授权号：ZL 201811431187.5\n11. 刘翠华，张勇，汪静；一种巨噬细胞吞噬能力促进剂；授权号：ZL 201710898729.9\n12. 刘翠华，汪静；一种抗结核分枝杆菌感染的蛋白TRIM27；授权号：ZL201610381995.X\n13. 刘翠华，许光华，汪静，李冰曦，严景华； 一种ERK信号通路抑制剂NdpA；授权号：ZL201610213178.3\n14. 刘翠华，汪静，李冰曦，鲁燕；一种结核分枝杆菌分泌蛋白的泛素结合结构域；授权号：ZL201410061782.X\n15. 刘翠华，汪静，李冰曦，葛浦浦；一种重组卡介苗及其构建与应用；授权号：ZL201410482225.5\n16. 刘翠华，李杰，汪静；一种Erk信号通路抑制剂；授权号：ZL201410523217.0\n17. 刘翠华，汪静；一种使p-JNK和p-p38去磷酸化的结核分枝杆菌分泌蛋白PtpA；授权号：ZL201310466907.2", "project": null, "award": "2003-2006 世界卫生组织，“生物技术与生物医学工程科研奖学金”\n2005 广东省教育厅，“南粤优秀研究生”\n2011 中国科学院，“青年创新促进会会员”\n2015 中国科学院，“青年创新促进会优秀会员”\n2018 中科院微生物研究所第二十届所长奖教金优秀奖\n2018 “国家杰出青年基金”\n2018 科技部“创新人才推进计划中青年科技创新领军人才”\n2019 “国家“万人计划科技创新领军人才”\n2019 作为团队成员获“求是杰出科技成就集体奖”\n2021 中国科学院大学“校级研究生优秀课程”\n2021 中国科学院大学“院级研究生优秀课程”\n2022 中国科学院“优秀导师奖”", "paper": "1. Chai Q#, Yu S#, Zhong Y#, Lu Z, Qiu C, Yu Y, Zhang X, Zhang Y, Lei Z, Qiang L, Li B, Pang Y, Qiu X-B*, Wang J*, Liu CH*. A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin. Science 2022, 378(6616): eabq0132.\n2. Wu B#, Qiang L#, Zhang Y#, Fu Y#, Zhao M, Lei Z, Lu Z, Wei Y, Dai H, Ge Y, Liu M, Zhou X, Peng Z, Li H, Cui C, Wang J, Zheng H, Liu CH*, Zhang L*. The deubiquitinase OTUD1 inhibits colonic inflammation through suppressing RIPK1-mediated NF-κB signaling. Cellular & Molecular Immunology 2022, 19: 276-289.\n3. Liu CH*, Rao Y*, Gao D*, Wan L*, Zhang L*. Editorial: Ubiquitin Code: From Cell Biology to Translational Medicine. Frontiers in Cell and Developmental Biology 2021, 9: 791967.\n4. Zhang F#, Yu S#, Chai Q#, Wang J#, Wu T, Liu R, Liu Y, Liu CH*, Pang Y*. HDAC6 contributes to human resistance against Mycobacterium tuberculosis infection via mediating innate immune responses. FASEB Journal 2021, 35: e22009.\n5. Hu Q#, Tong H#*, Wang J, Ge P, Zhu L, Liu CH, Zhang JR, Dong X*. A Novel Aquaporin Subfamily Imports Oxygen and Contributes to Pneumococcal Virulence by Controlling the Production and Release of Virulence Factors. mBio 2021, 12(4): e0130921.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/W020190702385622657813.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究组长", "office_address": "北京市朝阳区北辰西路1号院3号，A426室，中国科学院微生物研究所", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/t20181109_5168622.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "细胞生物学及分子病毒学研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "yex@im.ac.cn", "job_title": "研究员", "abstracts": "叶昕，研究员，博士生导师。1980-1984年厦门大学学士，1984-1987年中科院上海细胞生物学研究所硕士，1987-1990年中国医学科学院肿瘤研究所博士，1990-1992年中科院上海生物化学研究所，1992-1993年中科院上海生物工程中心副教授，1994-1995年美国洛克菲勒大学博士后，1995-1998年美国哥伦比亚大学博士后，1998-2000年美国伊利诺伊斯大学芝加哥分校资深研究员，2000-2003年美国贝勒医学院讲师，2003-2005年美国哈佛医学院讲师，2005年至今中科院微生物所研究员、博士生导师。", "directions": "1、流感病毒复制的分子机制及抗病毒天然免疫的调控机理\n2、乙型肝炎病毒调控细胞周期/细胞凋亡及肝癌发生发展的机理", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "1. 叶昕；张立新；秦玉洁；刘雪婷；叶榛；张敬宇，化合物AJ-4在制备治疗或预防抗流感病毒药物中的应用，专利授权号：ZL201510644254.1，授权日期：2019.01.15。\n2. 叶昕；张立新；叶榛；代焕琴；秦玉洁，化合物ID45在制备治疗或预防流感病毒药物中的应用，专利授权号：ZL201510359166.7,授权日期：2019.01.15。\n3. 叶昕；张立新；秦玉洁；刘雪婷；叶榛；张敬宇，化合物AJ-2在制备治疗或预防抗流感病毒药物中的应用，专利授权号：ZL201510644234.4，授权日期：2019.02.12。\n4. 叶昕；张军杰；刘婷；童晓梅；李刚，含有A型流感特异性启动子的重组细胞及其应用，专利授权号：ZL201010532889.X，授权日期：2012.12.19。", "project": "1、流感病毒复制的分子机制及抗病毒天然免疫的调控机理\n2、乙型肝炎病毒调控细胞周期/细胞凋亡及肝癌发生发展的机理", "award": "2011年和2015年微生物所所长奖教金", "paper": "1. Qi Liu, Ningning Liu, Qilin Shangguan, Fang Zhang, Wenjia Chai, Xin Zhao, Zhiwei Li, Dandan Qi, and Xin Ye, LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1. Sci Rep. 2019; 9: 11593.\n2. Xinda Li, Guijie Guo, Min Lu, Wenjia Chai, Yucen Li, Xiaomei Tong, Jing Li, Xiaojuan Jia, Wenjun Liu, Dandan Qi, Xin Ye. Lnc-MxA inhibits IFN-β transcription via forming RNA-DNA triplexes at its promoter. J Virol. 2019, DOI: 10.1128/JVI.00786-19.\n3. Dandan Qi, Lei Hu, Tong Jiao, Tinghong Zhang, Xiaomei Tong, Xin Ye. Phosphatase Cdc25A negatively regulates antiviral immune response by inhibiting TBK1 activity. J Virol. 92(19):e01118-18, 2018.\n4. Wenjia Chai, Jing Li, Qilin Shangguan, Qi Liu, Xinda Li, Dandan Qi, Xiaomei Tong, Wenjun Liu, Xin Ye. Lnc-ISG20 inhibits influenza A virus replication by enhancing ISG20 expression. J Virol. 92(16):e00539-18, 2018.\n5. Ningning Liu, Qi Liu, Xiaohai Yang, Fang Zhang, Xinda Li, Yuanwu Ma, Feifei Guan, Xin Zhao, Zhiwei Li, Lianfeng Zhang, Xin Ye. Hepatitis B virus-upregulated lnc-HUR1 promotes cell proliferation and tumorigenesis by blocking p53 activity. Hepatology. 2018, 68(6):2130-2144., 2018.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/W020200325615842226559.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/t20200325_5519787.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "微生物基因组学研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "zhubaoli@im.ac.cn", "job_title": "研究员", "abstracts": null, "directions": "重要病原微生物\n人体肠道微生物菌群\n细菌耐药性的进化与传播\n人体肠道微生物菌群与人体健康之间的关系", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "用于防治细菌性阴道病的詹氏乳杆菌，ZL201210347715.5\n一株詹氏乳杆菌及其应用，ZL201410535541.4\n一株弯曲乳杆菌及其应用，ZL201410446067.8\n一种检测结核分枝杆菌复合群的引物对及其应用，201410111291.1\n一种检测结核分枝杆菌方法及其专用引物，201110130415.7\n用于检测人乳头瘤病毒的试剂，201010517520.1", "project": "比较基因组分析多粘菌素耐药基因mcr-1\n病原细菌可移动遗传原件在肠道微生态环境中的进化分析研究", "award": "Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nature Communications. 4: 2151. DOI: 10.1038/ncomms3151.（IF 10.02）\nDissemination of the mcr-1 colistin resistance gene, Lancet Infect. Dis.16, 146-147. (IF 19.297)\nDietary shifts influenced by livestock grazing shape the gut microbiota composition and co-occurrence networks in a local rodent species, Journal of Animal Ecology. 1-13. (IF 4.459)\nInulin can alleviate metabolism disorders in ob/ob mice by partially restoring leptin-related pathways mediated by gut microbiota[J]. Genomics, proteomics & bioinformatics, 17(1): 64-75.（IF=6.615）\nAntibiotic resistance gene reservoir in live poultry markets. Journal of Infection.78.445-453 (IF=5.099)", "paper": "Hu Yongfei, Yang Xi, Qin Junjie, Lu Na, Cheng Gong, Wu Na, Pan Yuanlong, Li Jing, Zhu Liying, Wang Xin, Meng Zhiqi, Zhao Fangqing, Liu Di, Ma Juncai, Qin Nan, Xiang Chunsheng, Xiao Yonghong, Li Lanjuan, Yang Huanming, Wang Jian, Yang Ruifu, George F. Gao, Wang Jun, Zhu Baoli*. (2013) Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nature Communications. 4: 2151. DOI: 10.1038/ncomms3151.（IF 10.02）\nHu Yongfei , Liu Fei , Lin Ivan Y. C. , Gao George F. , and Zhu Baoli*. (2016) Dissemination of the mcr-1 colistin resistance gene, Lancet Infect. Dis.16, 146-147. (IF 19.297)\nGuoliang Li, Jing Li, Kevin D. Kohl, Baofa Yin, Wanhong Wei, Xinrong Wan, Baoli Zhu, Zhibin Zhang. (2018) Dietary shifts influenced by livestock grazing shape the gut microbiota composition and co-occurrence networks in a local rodent species, Journal of Animal Ecology. 1-13. (IF 4.459)\nSong Xiaofeng, Zhong Liang, Lyu Na, Liu Fei, Li Boxing, Hao Yanan, Xue Yong, Li Jing, Feng Yuqing, Ma Yue, Hu Yongfei*, Zhu Baoli*.2019 Inulin can alleviate metabolism disorders in ob/ob mice by partially restoring leptin-related pathways mediated by gut microbiota[J]. Genomics, proteomics & bioinformatics, 17(1): 64-75.（IF=6.615）\nYanan Wanga,b,c,1, Yongfei Hud,b,1, Jian Cao b,e, Yuhai Bi b, Na Lv b, Fei Liub, Shihao Liang b, Yi Shi b,e, Xinan Jiaoa,f, George Fu Gao b,e, Baoli Zhub,e,g,h,i,*.2019 Antibiotic resistance gene reservoir in live poultry markets. Journal of Infection.78.445-453 (IF=5.099)", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/W020200325635117060950.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员 博士生导师", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/t20200325_5519817.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "糖化学与抗感染药物研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806106", "email": "lixb@im.ac.cn", "job_title": "研究员", "abstracts": "研究组长：李学兵 研究员 博士生导师 电话：010-64806106 电子邮件：lixb@im.ac.cn 通讯地址：北京市朝阳区北辰西路1号院3号 邮政编码：100101", "directions": "1.寡糖合成新方法研究；\n2.病原微生物抑制剂研究；\n3.微生物快速检测方法研究。", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "1.李学兵，程水红，王彦，朱国锋，马丽英，邵一鸣。双靶点抗HIV糖肽化合物及其应用，专利号：ZL201510689359.9，授权日期：2018.11.13。\n2.李学兵，程水红，马丽英，邵一鸣。一种糖基化多肽及其制备方法和其应用。专利号：ZL201310704596.9，授权日期：2018.3.13。\n3.李学兵，程水红，韩婧，王一仁，山形达也。类糖鞘脂化合物及其制备方法与应用。专利号：ZL201410095218.X，授权日期：2017.7.14。\n4.李学兵，未金花，郑隆堂，吕迅。流感病毒唾液酸寡糖功能受体及其合成方法，专利号：ZL201310494997.6，授权日期：2016.5.18。\n5.李学兵，李长庚，张振兴。一种糖肽的合成方法。专利号：ZL201410092568.0，授权日期：2015.12.2。\n6.李学兵，傅立峰，高福，严景华，毕玉海，吴燕。四价扎那米韦的制备方法与应用，专利号：ZL201410068706.1，授权日期：2015.10.28。\n7.李学兵，未金花，郑隆堂，吕迅，毕玉海，高福，刘文军，严景华。唾液酸寡糖-金纳米粒子及其制备方法及应用，专利号：ZL201310495249.X，授权日期：2015.7.15。", "project": null, "award": null, "paper": "1.Chen Wang, Shuihong Cheng, Yuanyuan Zhang, Yibo Ding, Huihui Chong, Hui Xing, Shibo Jiang,Xuebing Li, Liying Ma. Long-acting HIV-1 fusion inhibitory peptides and their mechanisms of action.Viruses2019,11(9), 811.\n2.Shuihong Cheng, Paeton L. Wantuch, Megan E. Kizer, Dustin R. Middleton, Ruitong Wang, Mikaela DiBello, Mingli Li, Xing Wang,Xuebing Li, Vasanthi Ramachandiran, Fikri Y. Avci, Fuming Zhang, Xing Zhang, Robert J. Linhardt. Glycoconjugate synthesis using 3.chemoselective ligation.Organic & Biomolecular Chemistry2019,17, 2646–2650.\n4.Zhenxing Zhang, Xiaoxiao Qi, Jinfeng Chai, Peixing Wu, Xun Lv*, Shuihong Cheng*,Xuebing Li*. Detection of glycan-binding proteins using glycan-functionalized quantum dots and gold nanoparticles.Journal of Carbohydrate Chemistry2018, 1-11.\n5.Xun Lv, Hongzhi Cao, Baixue Lin,* Wei Wang, Wande Zhang, Qian Duan, Yong Tao, Xue-Wei Liu,Xuebing Li*. Synthesis of sialic acids, their derivatives and analogues using a whole-cell catalyst.Chemistry-A European Journal2017,23, 15143-15149.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/W020200325596735980944.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/t20200325_5519752.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "调节性T细胞研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806075", "email": "zhouxy@im.ac.cn", "job_title": "博士、研究员", "abstracts": null, "directions": "调节性T细胞（Treg）的抑制机理及其免疫调控机制研究，探索选择性干预Treg细胞和其他效应性T细胞，进行肿瘤、感染性和自身免疫性疾病的治疗。\nTreg细胞的抑制机理及其免疫调控机制研究\n肿瘤TCR-T治疗研究", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "周旭宇，张建华，张伟，黄满；一种优化型HLA-I类转基因小鼠的构建方法；专利号：ZL 2015 1 0136784.5；授权日期：2019年7月12日\n周旭宇，魏训东，徐威，张建华，黄满；HLA-A11限制性乙型肝炎病毒HBc141-151表位肽的T细胞受体及其应用；专利号：201911170818.7 (受理)\n周旭宇，高福，赵欣，张会玲，璩骁，郭洁，张建华；埃博拉病毒感染细胞模型的制备与应用；专利号：201911147438.1 (受理)", "project": null, "award": null, "paper": "1. Zhang Z, Zhou X. Foxp3 Instability Helps tTregs Distinguish Self and Non-self. Front Immunol. 2019 Sep 24; 10: 2226. doi: 10.3389/fimmu.2019.02226. eCollection 2019.\n2. Xueping Zhu, Wei Zhang, Jie Guo, Xuejie Zhang, Liping Li, Ting Wang, Jinghua Yan, Fuping Zhang, Baidong Hou, Ning Gao, George F Gao*, Xuyu Zhou*. Noc4L mediated ribosome biogenesis controls activation of regulatory T cell and conventional T cell. Cell Reports. 2019, 27(4): 1205-1220\n3. Krung Phiwpan, Xuyu Zhou*. MicroRNAs in regulatory T cells. Cancer Letters, 2018, 423, 80-85.\n4. Xundong Wei, Jianhua Zhang, Qianchong Gu, Man Huang, Wei Zhang, Jie Guo, Xuyu Zhou*. Reciprocal Expression of IL-35 and IL-10 Defines Two Distinct Effector Treg Subsets that Are Required for Maintenance of Immune Tolerance. Cell Reports. 2017, 21(7), 1853-1869.\n5. Zhongmei Zhang, Wei Zhang, Jie Guo, Qianchong Gu, Xueping Zhu, Xuyu Zhou*. Activation and Functional Specialization of Regulatory T Cells Lead to the Generation of Foxp3 Instability. Journal of Immunology. 2017, 198(7): 2612-2625.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/W020200326391005036711.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员、博士生导师", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/t20200326_5519908.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "T细胞免疫调控研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "mengsd@im.ac.cn", "job_title": "研究员", "abstracts": null, "directions": "乙肝病毒、宿主因子、细胞免疫研究", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": null, "award": null, "paper": "1. Zhen Liu, Xinghui Li, Lipeng Qiu, Xiaojun Zhang, Lizhao Chen, Sheng Cao, Fusheng Wang, Songdong Meng. 2009. Treg suppress CTL responses upon immunization with HSP gp96. European Journal of Immunology, 39:1-11\n2. Sheng Cao, Yang Li，Jin Li, Changfei Li, Zhang Wei, Zhengqi Yang, Songdong Meng. 2009. Quantitative determination of HER2 expression by confocal microscopy assay in CTCs of breast cancer. Oncology Reports (accepted)\n3. Songdong Meng, Debu Tripathy, Sanjay Shete, Raheela Ashfaq, Hossein Saboorian, Barbara Haley, Eugene Frenkel, David Euhus, Marilyn Leitch, Cynthia Osborne, Edward Clifford, Steve Perkins, Peter Beitsch, Amanullah Khan, Larry Morrison, Dorothee Herlyn, Leon WMM Terstappen, Nancy Lane, Jianqiang Wang, and Jonathan Uhr. 2006. uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues. Proceedings of the National Academy of Sciences of the United States of America，103(46): 17361-17365.\n4. Fehm T, Solomayer EF, Meng S, Tucker T, Lane N, Wang J, Gebauer G. 2005. Methods of isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy, 7(2):171-185\n5. Songdong Meng, Debasish Tripathy, Eugene P Frenkel, Sanjay Shete, Elizabeth Z Naftalis, James F Huth, Peter D Beitsch, Marilyn Leitch, Susan Hoover, David Euhus, Barbara Haley, Larry Morrison, Timothy P Fleming, Dorothee Herylyn, Leon WMM Terstappen, Tanja Fehm, Thomas F Tucker, Nancy Lane, Jianqiang Wang, Jonathan W Uhr. 2004. Circulating tumor cells in patients with breast cancer dormancy. Clinical Cancer Research, 10(24):8152-8162.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/W020181109586883985739.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员 博士生导师", "office_address": "北京市朝阳区北辰西路1号院3号，中国科学院微生物研究所", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/t20181109_5168618.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "T细胞分化与转录调控研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": null, "job_title": "博士、研究员", "abstracts": "张福萍，博士，研究员，博士生导师。2001年获中国预防医学科学院病毒学研究所免疫学博士。在美国Vanderbilt Univesity医学中心和美国国立卫生院（NIH/NIAID）做博士后。 2011年底回国在中国科学院微生物研究所任研究员。长期从事免疫学研究，在研究方向上的代表性研究成果分别发表于国际免疫学权威学术刊物Nature Immunology、Immunity、Journal of Experimental Medicine、PNAS。其中发表在Nature Immunology的文章被免疫学领域影响力最强的综述性期刊如Nature Review Immunol (2009; 9: 106-105)，Immunity (2009; 30: 646-655)和Curr Opin Immunol (2009; 21:146-152)广泛引用。对细胞免疫调控机制的研究积累了丰富的经验。", "directions": "T细胞分化为不同辅助性T细胞的转录调控机制\n病毒感染与免疫\n肠道菌群与肠炎发生机制研究", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": "病毒与宿主互作及致病机制研究\n病毒感染诱导TFH细胞分化机制的研究\n肠道菌群与肠炎易感基因致病机制的关系", "award": "获微生物所2019年度“教书育人奖”", "paper": "1. Han X, Huang H, Gao P, Zhang Q, Liu X, Jia B, Warren Strober, Hou B, Zhou X, Gao GF, Zhang F*. E-protein regulatory network links TCR signaling to effector Treg cell differentiation, Proc Natl Acad Sci U S A. 2019, 116(10): 4471-4480.\n2. Han X, Liu H, Huang H, Liu X, Jia B, Gao GF, Zhang F*. ID2 and ID3 are indispensable for Th1 cell differentiation during influenza virus infection in mice. Eur J Immunol. 2019, 49(3):476-489.\n3. Huang H, Li S, Zhang Y, Han X, Jia B, Liu H, Liu D, Tan S, Wang Q, Bi Y, Liu WJ, Hou B, Gao GF*, Zhang F*. CD8+T Cell Immune Response in Immunocompetent Mice during Zika Virus Infection. J Virol. 2017, 91(22).\n4. Gao P, Liu H, Huang H, Zhang Q, Strober W, Zhang F*. The Inflammatory Bowel Disease-Associated Autophagy Gene Atg16L1T300A Acts as a Dominant Negative Variant in Mice. J Immunol. 2017, 198(6): 2457-2467.\n5. Gao P, Han X, Zhang Q, Yang Z, Fuss IJ, Myers TG, Gardina PJ, Zhang F*, Strober W*(2014). Dynamic changes in E-protein activity regulate T reg cell development. J Exp Med. 2014; 211 (13):2651-68. * Correspondence Author", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/W020200326342071690754.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员，研究组长", "office_address": "中国科学院微生物研究所", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/t20200326_5519875.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "生物信息和计算生物学研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "junwang@im.ac.cn", "job_title": "研究员", "abstracts": "近年来测序技术的快速发展已经使生物学进入了大数据时代，生物数据的广度和数量能够使我们为很多之前未解决的生物学问题提供答案。利用生物信息学技术和统计学技术，将现有和未来的测序技术产生的组学数据进行有机的整合和分析，能够在多个领域和层面上解释生物学现象或者提出新的假设。在人和其他模式动物中我们利用多种组学研究他们的生态和进化，在医学的框架内研究健康以及疾病的发生，其中的一个重点则是不同菌群自身的结构功能，以及和宿主的相互作用及其影响。", "directions": "人体健康和疾病中的微生物组成、功能以及动力学\n人工智能方法及其在微生物组分析中的应用\n微生物与宿主相互作用的研究\n新型测序技术以及其他组学分析技术的应用", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "王军，赵娜；一种依赖Nanopore单分子测序的多组学测序及分析技术；申请号：201910048654.4", "project": null, "award": "2016 获弗拉芒自然基金支持\n2014 国家自费留学生奖学金\n2012 –2014 DFG博士奖学金\n2010 马普学会博士奖学金\n2008 –2010 欧盟Erasmus Mundus硕士奖学金", "paper": "Xizhan Xu, Zezheng Gao, Fuquan Yang, Yingying Yang, Liang Chen, Lin Han, Na Zhao, Jiayue Xu, Xinmiao Wang, Yue Ma, Lian Shu, Xiaoxi Hu, Na Lyu, Yuanlong Pan, Baoli Zhu, Linhua Zhao, Xiaolin Tong*,Jun Wang*. Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota are Attributable to Its Key Ingredient, Berberine.Genomics, Proteomics & Bioinformatics. In press\nWei Zheng, Yue Ma, Ai Zhao, Tingchao He, Na Lyu,Ziqi Pan, Geqi Mao, Yan Liu, Jing Li, Peiyu Wang,Jun Wang*, Baoli Zhu* & Yumei Zhang*. Compositional and functional differences in human gut microbiome with respect to equol production and its association with blood lipid level: a cross-sectional study.Gut Pathogens2019, 11:20 doi:10.1186/s13099-019-0297-6\nJun Wang#, Alexander Kurilshikov, Djawad Radjabzadeh, Williams Turpin, Kenneth Croitoru, Marc Jan Bonder, Matthew A. Jackson, Carolina Medina-Gomez, Fabian Frost, Georg Homuth, Malte Rühlemann, David Hughes, Han-na Kim, MiBioGen Consortium Initiative, Tim D. Spector, Jordana T. Bell, Claire J. Steves, Nicolas Timpson, Andre Franke, Cisca Wijmenga, Katie Meyer, Tim Kacprowski, Lude Franke, Andrew D. Paterson, Jeroen Raes，Robert Kraaij，Alexandra Zhernakova. Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative.Microbiome, 2018 6:101\nJun Wang#, Liang Chen, Na Zhao, Xizhan Xu, Yakun Xu, Baoli Zhu. Of genes and microbes: solving the intricacies in host genomes.Protein Cell. 2018 9(5):446-461\nJun Wang*, Louise B. Thingholm , Jurgita Skiecevičienė, *, Philipp Rausch, Martin Kummen, Johannes R. Hov, Frauke Degenhardt, Femke-Anouska Heinsen, Malte C. Rühlemann, Silke Szymczak, Kristian Holm, Tõnu Esko, Jun Sun, Mihaela Pricop-Jeckstadt, Samer Al-Dury, Pavol Bohov, Jörn Bethune, Felix Sommer, David Ellinghaus, Rolf K. Berge, Matthias Hübenthal, Manja Koch, Karin Schwarz, Gerald Rimbach, Patricia Hübbe, Wei-Hung Pan, Raheleh Sheibani-Tezerji, Robert Hösler, Philipp Rosenstiel, Mauro D’Amato, Katja Cloppenborg-Schmidt, Sven Künzel, Matthias Laudes, Hanns-Ulrich Marschal, Wolfgang Lieb, Ute Nöthlings, Tom H. Karlsen, John F. Baines, Andre Franke. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota.Nature Genetics, 2016 (48)1396–1406 (* contributed equally; Nature Genetics封面文章)", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/W020190702357575080178.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "组长", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/t20181109_5168628.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "重要生物制剂的生物合成与代谢调控研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806119", "email": "wenty@im.ac.cn", "job_title": "博士、研究员", "abstracts": null, "directions": "以微生物和真核细胞为研究对象，设计构建基因组规模代谢网络模型，并在其指导下利用系统生物学和合成生物学的方法，研究氨基酸、核苷酸及其衍生物的生物合成和代谢调控机制，阐明氨基酸、核苷酸代谢与肿瘤发生及代谢性疾病的相关性。解析重要生命活动和代谢过程中关键酶的晶体结构，指导蛋白质定向进化，改造酶分子特性。开发高效基因组编辑、新型调控元件、生物传感器等合成生物学技术，应用于重要生物基产品（氨基酸、核苷酸、维生素及有机胺等）和生物制剂（疫苗、抗体及生物大分子等）细胞工厂的构建及产业化。", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "1. Tingyi Wen, Liu Shuwen, Liang Yong, Shang Xiuling, Liu Qian, Wen Jifu, Zhang Yun. E. coli engineering bacteria producing 1, 5-pentanediamine through whole cell catalysis and application thereof. Patent No. US15122340 申请日：2016-08-29，授权日：2018-7-10。\n2. Tingyi Wen, Xiuling Shang, Yun Zhang, Shuwen Liu, Yong Liang, Yu Zhang. Recombinant strain producing L-amino acid, constructing method therefor and method for producing L-amino acid. Patent No. US14891622. 申请日：2015-02-4，授权日：2017-10-24。\n3. 温廷益，商秀玲，张芸，刘树文，梁勇，张宇。産 L-アミノ酸の組換え菌およびその構築方法。专利授权号：JP2016515651. 申请日：2015-02-4，授权日：2017-08-10。\n4. Tingyi Wen, Xiuling Shang, Yun Zhang, Shuwen Liu, Yong Liang, Yu Zhang. Recombinant strain producing L-amino acid, constructing method therefor and method for producing L-amino acid. Patent No. KR1020157032480. 申请日：2015-02-4，授权日：2018-10-26。\n5. 温廷益，张国强，邓爱华。標的細菌の制限修飾バリアを乗り越えて外来性 DNA を導入する方法。专利授权号：JP6140804. 申请日：2013-02-21，授权日：2017-05-12。", "project": "1. 基因组编辑和合成生物学工具的开发应用\n2. 网络模型设计构建高效合成氨基酸和维生素的菌种\n3. 研发氨基酸衍生物产品的高纯度低成本的全套生产技术", "award": "1. “从玉米到服装”入选中科院建院70周年创新成果展（2019年）\n2. 第三届中国-阿拉伯国家技术转移与创新合作大会“十项主推重要技术成果”（2019年）\n3. 第九届中国技术市场“金桥奖”先进个人奖（2018年）\n4. 中国科学院 “朱李月华优秀教师奖”（2015年）\n5. 银川市产学研合作奖（2014-2015年度）\n6. 中国科学院科技促进发展奖科技贡献奖（2014年度）\n7. 中国科学院“优秀研究生指导教师奖”（2013年）\n8. 政府特殊津贴（2007年）\n9. 中华中医药学会科学技术奖一等奖（2004年度）\n10. 中华中医药学会科学技术奖二等奖（2003年度）\n11. 天津市科技进步二等奖（2000年读）\n12. 天津市科技进步二等奖（2002年度）\n13. 天津市科技进步二等奖（1997年度）", "paper": "1. Aihua Deng, Zhaopeng Sun, Tiantian Wang, Di Cui, Lai Li, Shuwen Liu, Fei Huang and Tingyi Wen*. Simultaneous Multiplex Genome Engineering via Accelerated Natural Transformation in Bacillus subtilis. Frontiers in Microbiology. 2021, 12: 714449.\n2. Dalan Jing, Aihua Deng, Hongmei Wang, Yilin Chou, Xiaodan Jiang, Zhenxiang Chen, Xuemin Li, and Tingyi Wen*. Comparative Evaluation of Bandage Contact Lenses and Eye Patching after Bilateral Cataract Surgery. Journal of Ophthalmology. 2021, Article ID 2873543.\n3. 王雪亮，张芸*，温廷益*，整合组学数据的代谢网络模型研究进展，《科学通报》，2021，19：2393-2404。\n4. Hua Bai#, Huibin Lv#, Aihua Deng, Xiaodan Jiang, Xuemin Li*, Tingyi Wen* Lysobacter oculi sp. nov., isolated from human Meibomian gland secretions. Antonie van Leeuwenhoek 2020,113: 13-20.\n5. Shuwen Liu#, Haihan Xiao#; Fangfang Zhang, Zheng Lu; Yun Zhang, Aihua Deng, Zhongcai Li, Cui Yang, Tingyi Wen*, A seamless and iterative DNA assembly method named PS-Brick and its assisted metabolic engineering for threonine and 1-propanol production. Biotechnology for Biofuels, 2019, 12: 180.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202110/W020211019383948843064.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究组长", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202110/t20211019_6224033.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "病原微生物潜伏感染和耐药机理研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806072", "email": "mik@im.ac.cn", "job_title": "博士、项目研究员", "abstracts": "传染病严重影响正常的生活和工作。结核是由结核分枝杆菌引起的空气传播的疾病。结核主要以化疗为主，随着抗生素的广泛使用，耐药结核的流行成为世界的难题。另外，全球近1/4人口处于潜伏感染，由于免疫力降低，例如艾滋病毒感染或糖尿病，约有5-10%潜伏感染可能发生活动性结核病；因此潜伏感染人群是一个庞大的潜在“患者库”。课题组利用组学、合成生物学、结构生物学等方法，研究结核分枝杆菌等人类重要病原体的潜伏感染和耐药分子机制，为新治疗诊断方法提供科学指导。课题组主要以分枝杆菌等人类重要的病原体为研究对象，主要研究内容：1）分枝杆菌潜伏感染和复发机制2）分枝杆菌的耐药机制", "directions": "结核分枝杆菌等人类重要的病原体的潜伏感染和耐药分子机理", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": "国家自然科学基金面上项目：分枝杆菌五肽重复序列蛋白MfpA在分枝杆菌致病过程的分子作用机制及对药物干扰的影响2020-2023主持\n国家自然科学基金面上项目：结核分枝杆菌旋转酶的翻译后修饰及相互作用蛋白对DNA拓扑结构及药物抗性的影响2017-2020主持\n国家自然科学基金面上项目：与活性氧相关的结核分枝杆菌异烟肼耐药机制研究2013-2016主持\n国家自然科学基金面上项目：结核分枝杆菌广谱胁迫蛋白Rv1996在潜伏感染中的调控机理2010-2013主持\n中国科学院微生物研究所基础前沿项目：病原微生物广泛耐药机理及相关药物研究，2011-2013主持\n国家重点研发计划：食源性生物监管标准化基因数据库的构建，2019-2021课题主持\n国家重点研发计划：调控病原菌感染致病的新型宿主免疫蛋白分子的研究，2017-2022参与\n科技部973项目：重要病原菌与宿主相互作用分子机制的研究，2012-2016参与\n中国科学院知识创新工程人才引进资助项目：结核分枝杆菌的潜伏复活机理，2009 -2011 主持\nCEPAMS collaborative research funding:Investigation of DNA gyrase-interacting proteins inMycobacterium tuberculosis, and the implications for TB therapy, 2020-\nStructural analysis ofMycobacterium tuberculosisdrug-resistance-related proteins, 2017- 2019\nInternational Joint Research Project of the Institute of Medical Science, University of Tokyo: Co-infection of Mycobacterium and HIV, 2016-\nTsinghua University-Gates Foundation: The systemic analysis of redox maintenance for latency in mycobacteria--To explore the basis for latency in tuberculosis (2015-2016)", "award": null, "paper": "Lipeng Feng, Julia E. A. Mundy, Clare E. M. Stevenson, Lesley A. Mitchenall, David M. Lawson,Kaixia Mi*, Anthony Maxwell*, The pentapeptide-repeat protein, MfpA, interacts with mycobacterial DNA gyrase as a DNA T-segment mimic,Proc Natl Acad Sci U S A,接收, (通讯)\nXiaojing Li, Yujiao Zhang, Xintong Zhou, Xinling Hu, Yixuan Zhou, Di Liu, Anthony Maxwell, Kaixia Mi*, The plasmid-borne quinolone resistance protein QnrB, a novel DnaA-binding protein, increases the bacterial mutation rate by triggering DNA replication stress.Mol Microbiol,2019, (通讯)\nQingqing Zhang, Huijuan Liu, Xiang Liu, Dunquan Jiang, Bingjie Zhang, Hongliang Tian, Cheng Yang, Luke W Guddat, Haitao Yang, Kaixia Mi, Zihe Rao*, Discovery of the first macrolide antibiotic binding protein in Mycobacterium tuberculosis: a new antibiotic resistance drug target.Protein Cell,2018\nQiaoling Yan, Dunquan Jiang, Lanfang Qian, Qingqing Zhang, Wei Zhang, Weihong Zhou, Kaixia Mi, Luke Guddat, Haitao Yang, Zihe Rao*, Structural insight into the activation of pknI kinase from M. tuberculosis via dimerization of the extracellular sensor domain,Structure,2017\nQiong Jia, Xinling Hu, Dawei Sh, Yan Zhang, Meihao Sun, Jianwei Wang, Kaixia Mi*, Guofeng Zhu*, Universal stress protein Rv2624c alters abundance of arginine and enhances intracellular survival by ATP binding in mycobacteria,Sci Rep,2016, (通讯)", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/W020200324548297962617.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "课题组组长", "office_address": "北京市朝阳区北辰西路1号院微生物所", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202003/t20200323_5518426.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "病原致病机理及阻断研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806182", "email": "jxqi@im.ac.cn", "job_title": "研究员", "abstracts": null, "directions": "基于病原微生物入侵机制的免疫原设计和抑制剂设计", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": "采用X-ray，Cryo-EM以及SAXS等结构生物学手段，解析病原微生物入侵宿主细胞的分子机制，把不同层面、不同尺度的结构信息整合起来，并结合生化功能，解析病原微生物侵入宿主的分子机制。\n鉴定微生物优势免疫原，开发基于优势T/B表位信息的免疫原理性设计和从头设计新方法，开发人工设计蛋白质疫苗、重组亚单位通用疫苗和纳米颗粒疫苗。\n基于病原生命周期中关键酶设计小分子抑制剂，揭示抑制剂的作用机制，分析评估抑制剂的药代动力学特征及其安全有效性，优化抑制剂的结构，获得高效阻断病原体的广谱抑制剂。", "award": "2011年获得北京市科学技术奖，一等奖\n2016年中国生命科学领域十大进展\n2017年获得中华预防医学会科学技术奖，一等奖\n2021 Chinese Scientists with Cell Press Best Paper Award 2020\n2021年国家“万人计划”科技创新领军人才\n2021年北京市朝阳区“凤凰计划”高层次人才\n2021 Clarivate Highly Cited Researcher 2021", "paper": "1.Pengcheng Han, Linjie Li, Sheng Liu, Qisheng Wang, Di Zhang, Zepeng Xu, Pu Han, Xiaomei Li, Qi Peng, Chao Su, Baihan Huang, Dedong Li, Rong Zhang, Mingxiong Tian, Lutang Fu, Yuanzhu Gao, Xin Zhao, Kefang Liu, Jianxun Qi*, George F Gao* & Peiyi Wang*. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2, Cell, 2022, 185: 630-640.\n2.Pengcheng Han, Chao Su, Yanfang Zhang, Chongzhi Bai, Anqi Zheng, Chengpeng Qiao, Qing Wang, Sheng Niu, Qian Chen, Yuqin Zhang, Weiwei Li, Hanyi Liao, Jing Li, Zengyuan Zhang, Heecheol Cho, Mengsu Yang, Xiaoyu Rong, Yu Hu, Niu Huang, Jinghua Yan, Qihui Wang, Xin Zhao, George Fu Gao*, & Jianxun Qi*, Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants, Nature Communications, 2021, 12: 6103.\n3.Kefang Liu, Xiaoqian Pan, Linjie Li, Feng Yu, Anqi Zheng, Pei Du, Pengcheng Han, Yumin Meng, Yanfang Zhang, Lili Wu, Qian Chen, Chunli Song, Yunfei Jia, Sheng Niu, Dan Lu, Chengpeng Qiao, Zhihai Chen, Dongli Ma, Xiaopeng Ma, Shuguang Tan, Xin Zhao, Jianxun Qi*, George F Gao* & Qihui Wang*. Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species, Cell, 2021, 184: 3438-3451.\n4.Qihui Wang, Yanfang Zhang, Lili Wu, Sheng Niu, Chunli Song, Zengyuan Zhang, Guangwen Lu, Chengpeng Qiao, Yu Hu, Kwok-Yung Yuen, Qisheng Wang, Huan Zhou, Jinghua Yan and Jianxun Qi*, Structural and functional basis of COVID-19 virus entry by using human ACE2; Cell, 2020, 181:894-04 (入选Faulty of 1000).\n5.Yingzi Cui, Ruchao Peng, Hao Song, Zhou Tong, Xiao Qua, Sheng Liua, Xin Zhaoa, Yan Chaia, Peiyi Wange, George F. Gao & Jianxun Qi*, Molecular basis of Coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1，PNAS, 2020, 117:18711-18718.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202006/W020200609605963162446.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究组长", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202006/t20200609_5603804.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "肠道粘膜免疫与疾病调控研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806162", "email": "wangshuo@im.ac.cn", "job_title": "研究员", "abstracts": null, "directions": "肠道黏膜免疫淋巴细胞在炎-癌转化和病原菌感染过程中的调控机制\n肠道菌群在生理和病理情况下与肠道淋巴细胞的互作调控机制\n呼吸道黏膜免疫系统抗感染机制", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": "1. 肠道黏膜免疫淋巴细胞在炎-癌转化和病原菌感染过程中的调控机制。分析结肠癌肿瘤浸润固有淋巴细胞类型，筛选固有淋巴细胞表达的与结肠癌进程密切相关的特征性分子，并进一步研发临床应用靶向药物。\n2. 研究肠道菌群在生理和病理情况下与肠道淋巴细胞的互作调控机制。研究肠道菌群与肠道黏膜免疫系统建立和功能调控的关系。\n3. 呼吸道黏膜免疫系统抗感染机制。系统揭示肺部区域免疫的抗感染免疫应答，通过多组学手段鉴定黏膜免疫细胞亚群，研究呼吸道黏膜的免疫应答规律，为疫苗设计和药物研发提供理论基础。", "award": "2022年获得北京市自然科学二等奖\n2019年获评中国科学院青年创新促进会优秀会员\n2018年获得北京市科技进步一等奖\n2017年获国家自然科学基金优秀青年基金资助\n2015年入选中国科学院青年创新促进会会员", "paper": "1. Zhang X#, Yu D#, Wu D#, Gao X, Shao F, Zhao M, Wang J, Ma J, Wang W, Qin X, Chen Y*, Xia P*, Wang S*. Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance. Cell Host & Microbe. 2023.31(3):418-432.e8.\n2. Zhu F#, Ma J#, Li W#, Liu Q#, Qin X, Qian Y, Wang C, Zhang Y, Li Y, Jiang D, Wang S*, Xia P*. The orphan receptor Nur77 binds cytoplasmic LPS to activate the non-canonical NLRP3 inflammasome. Immunity. 2023. 56, 753–767.\n3. Zhao M#, Shao F#, Yu D#, Zhang J, Liu Z, Ma J, Xia P*, Wang S*. Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis. Nature Communications. 2022. 13(1):7600.\n4. Shao F, Yu D, Xia P, Wang S*. Dynamic regulation of innate lymphoid cells in the mucosal immune system. Cellular & Molecular Immunology. 2021. 18(6):1387-1394.\n5. Zhu F#, Yu D#, Qin X#, Qian Y#, Ma J, Li W, Liu Q, Wang C, Zhang Y, Li Y, Jiang D, Wang S*, Xia P*. The neuropeptide CGRP enters the macrophage cytosol to suppress the NLRP3 inflammasome during pulmonary infection. Cellular & Molecular Immunology. 2023. 20(3):264-276.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202005/W020230418396591401724.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202005/t20200513_5578985.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "分子病毒及疫苗研发研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64807980", "email": "dengt@im.ac.cn", "job_title": "研究员", "abstracts": null, "directions": "流感病毒复制机制及抗病毒策略研发", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "一种提高流感病毒疫苗株产量的方法，专利授权号ZL 2012 1 0299497.2, 授权日期：2015.08.05\n甲型流感病毒亚型基因型定型的方法，专利授权号ZL 2014 1 0354092.3 授权日期：2017.01.18", "project": "1. 流感病毒基因组RNA转录与复制的发生、调控及其结构基础；\n2. 流感病毒RNA序列与结构特征参与病毒RNA合成、运输和选择性包装的分子机制；\n3. 病毒-宿主相互作用参与病毒RNA合成及其在跨种传播中的作用和机制；\n4. 新型流感病毒疫苗及抗流感药物研发。", "award": null, "paper": "1. Yang R, Pan M, Guo J, Huang Y, Zhang QC*, Deng T*, Wang J*. 2024. Mapping of the influenza A virus genome RNA structure and interactions reveals essential elements of viral replication. Cell Rep., 43(3):113833. doi: 10.1016/j.celrep.2024.113833.\n2. Zhang L, Shao Y, Wang Y, Yang Q, Guo J, Gao GF, Deng T*. 2024. Twenty natural amino acid substitution screening at the last residue 121 of influenza A virus NS2 protein reveals the critical role of NS2 in promoting virus genome replication by coordinating with viral polymerase. J. Virol., 98(1):e0116623. doi: 10.1128/jvi.01166-23.\n3. Cao M, Jia Q, Li J, Zhao L, Zhu L, Zhang Y, Li S, Deng T*. 2024. Naturally occurring PAE206K point mutation in 2009 H1N1 pandemic influenza viruses impairs viral replication at high temperatures. Virol. Sin., 39(1):71-80. doi: 10.1016/j.virs.2023.11.005.\n4. Zhang L, Wang Y, Shao Y, Guo J, Gao GF*, Deng T*. Fine Regulation of Influenza Virus RNA Transcription and Replication by Stoichiometric Changes in Viral NS1 and NS2 Proteins. J. Virol., 97(5):e0033723. doi: 10.1128/jvi.00337-23.\n5. Shu C, Sun Q, Fan G, Peng K, Yu Z, Luo Y, Gao S, Ma J, Deng T, Hu S, Wu L. 2024. VarEPS-Influ: an risk evaluation system of occurred and virtual variations of influenza virus genomes. Nucleic Acids. Res., 52(D1):D798-D807. doi: 10.1093/nar/gkad912.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202001/W020221011560020276239.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202001/t20200110_5485362.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "新型疫苗及抗体工程研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64807808", "email": "Yanjh@im.ac.cn", "job_title": "研究员", "abstracts": "严景华博士，中国科学院微生物研究所研究员，主要从事基于结构的疫苗设计、抗体药物作用机制及抗体药物研发、人源抗体筛选及动物来源抗体的人源化等研究。", "directions": "基于结构的疫苗设计\n抗体药物作用机制及抗体药物研发\n人源抗体筛选及动物来源抗体的人源化", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": null, "award": "2014年国家科技进步奖二等奖\n2017年中华预防医学会科学技术奖一等奖\n2019年求是杰出科技成就集体奖\n2020年中国科学院优秀导师奖\n2020年全国创新争先奖\n2020年全国抗击新冠肺炎先进个人\n2020年度全国三八红旗集体\n2021年中国科学院优秀导师奖\n2021年中国科学院大学“领雁银奖·振翅奖”", "paper": "1. Wang F, Li L, Dou Y, Shi R, Duan X, Liu H, Zhang J, Liu D, Wu J, He Y, Lan J, Lu B*, Feng H*, Yan J*, Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants. Emerging Microbes & Infections 2022, 11:548-51.\n2. Duan X, Shi R, Liu P, Huang Q, Wang F, Chen X, Feng H, Huang W*, Xiao J*, Yan J*. A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants. Signal Transduction and Targeted Therapy. 2022, 7:23.\n3. Tian S, Ji K, Wang M, Wang F, Wang H, Huang W*, Huang Q*, Yan J*. Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice, Cell Discovery 7(1) (2021) 91.\n4. Y. Du, R. Shi, Y. Zhang, X. Duan, L. Li, J. Zhang, F. Wang, R. Zhang, H. Shen, Y. Wang, Z. Wu, Q. Peng, T. Pan, W. Sun, W. Huang, Y. Feng, H. Feng, J. Xiao, W. Tan, Y. Wang, C. Wang, J. Yan*, A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants, Nature Communications 12(1) (2021) 5000.\n5. Huang Q, Ji K, Tian S, Wang F, Huang B, Tong Z, Tan S, Hao J, Wang Q, Tan W*, Gao G.F*, Yan J*. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. Nature Communication. 2021, 12(1): 776.", "social_job": null, "picture": "https://im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/W020211108335763554920.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究组长", "office_address": "北京市朝阳区北辰西路1号", "origin": "https://im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201811/t20181109_5168596.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "病毒传播预警与致病机制青年研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806989", "email": "Beeyh@im.ac.cn", "job_title": "博士、研究员", "abstracts": null, "directions": "变异或新型流感等病毒的监测预警、遗传演化、致病和传播机制及生物安全综合防治策略的研究。", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": null, "award": "《禽流感病毒感染人的生态与分子机制研究》荣获2017年中华预防医学会科学技术奖，一等奖。\n2019年代表中国大陆竞选“APEC Science Prize for Innovation, Research and Education (ASPIRE)”，提名。", "paper": "1. Yuhai Bi#, Shuguang Tan#, Yang Yang#, Gary Wong, Min Zhao, Qingchao Zhang, Qiang Wang, Xiaonan Zhao, Liqiang Li, Jing Yuan, Hao Li, Hong Li, Wen Xu, Weifeng Shi, Chuansong Quan, Rongrong Zou, Jianming Li, Haixia Zheng, Liuqing Yang, William J Liu, Di Liu, Huijun Wang, Yantao Qin, Lei Liu, Chengyu Jiang, Wenjun Liu, Lin Lu, George F Gao*, Yingxia Liu*. Clinical and immunological characteristics of human infections with H5N6 avian influenza virus. Clinical Infectious Diseases. 2019 Mar 19;68(7):1100-1109. (IF=9.055, Top 3.37%, citation: 3 times).\n2. Yang Yang#, Gary Wong#, Liuqing Yang, Shuguang Tan, Jianming Li, Bing Bai, Zhixiang Xu, Hong Li, Wen Xu, Xiaonan Zhao, Chuansong Quan, Haixia Zheng, William J. Liu, Wenjun Liu, Lei Liu, Yingxia Liu*, Yuhai Bi*, George F. Gao*. Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings. Journal of Infection, 2019 Mar;78(3):241-248. (IF=5.099, Top:10.11%, Citation: 1 time).\n3. Chuansong Quan#, Weifeng Shi#, Yang Yang#, Yongchun Yang, Xiaoqing Liu, Wen Xu, Hong Li, Juan Li, Qianli Wang, Zhou Tong, Gary Wong, Cheng Zhang, Sufang Ma, Zhenghai Ma, Guanghua Fu, Zewu Zhang, Yu Huang, Houhui Song, Liuqing Yang, William J. Liu, Yingxia Liu, Wenjun Liu, George F. Gao*, Yuhai Bi*. New threats of H7N9 influenza virus: the spread and evolution of highly and low pathogenic variants with high genomic diversity in Wave Five. Journal of Virology, 2018 May 14;92(11). pii: e00301-18. doi: 10.1128/JVI.00301-18. (IF=4.324, Top 22.22%, Citation: 20 times)\n4. Yuhai Bi#, Quanjiao Chen#, Qianli Wang#, Jianjun Chen#, Tao Jin, Gary Wong, Chuansong Quan, Jun Liu, Jun Wu, Renfu Yin, Lihua Zhao, Mingxin Li, Zhuang Ding, Rongrong Zou, Wen Xu, Hong Li, Huijun Wang, Kegong Tian, Guanghua Fu, Yu Huang, Alexander Shestopalov, Shoujun Li, Bing Xu, Hongjie Yu, Tingrong Luo, Lin Lu, Xun Xu, Yang Luo, Yingxia Liu*, Weifeng Shi*, Di Liu* and George Fu Gao*. Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host Microbe. 2016 Dec 14;20(6):810-821. (IF=15.753, Top 2.26%, Citation: 74 times).\n5. Shuo Su, Gary Wong, Xiangguo Qiu, Gary Kobinger, Yuhai Bi*, Jiyong Zhou*. Diagnostic strategies for Ebola virus detection. Lancet Infectious Diseases. 2016. March. Vol. 16,(3) :294–295. (IF=27.516, Top 1.12%, Citation: 36 times).", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201911/W020191125748834559284.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "项目研究员", "office_address": "北京市朝阳区北辰西路1号院微生物所", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/201911/t20191125_5442572.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "病原感染与抗体药物研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64806927", "email": "wangqihui@im.ac.cn", "job_title": "研究员", "abstracts": "近年来重要囊膜病毒，如新冠病毒（SARS-CoV-2）、中东呼吸综合征冠状病毒（MERS-CoV）、重症急性呼吸综合征冠状病毒（SARS-CoV）、寨卡病毒等，引起的新发突发传染病疫情频发，直接威胁公共健康与国家安全，造成了重大的经济损失，亟需以基础研究为指导，开发出高效的疫苗和药物，尤其是广谱的疫苗与广谱药物。在病毒与宿主的相互作用过程中，囊膜病毒首先通过表面糖蛋白与宿主细胞上特定的受体识别和结合，这一步在一定程度上决定了病毒的跨种传播和致病机制。同时囊膜病毒与宿主受体的作用界面也是干预病毒感染的重要靶点。宿主产生的中和抗体即是通过结合囊膜蛋白，阻断病毒与受体的结合从而抑制病毒感染。因此，课题组聚焦可引发重大传染性疾病的囊膜病毒：（1）以病毒入侵机制的研究为基础，深度解析病毒进入细胞的全过程，精确锁定影响病毒入侵的关键靶点；（2）结合单细胞测序、生物信息学分析等手段，系统阐明宿主的抗体应答规律，建立抗体表位与功能知识图谱，精准识别病毒的广谱干预靶点，研究过程中获得的高效中和抗体可继续开发，为治疗病毒感染提供候选药物；（3）通过以结构为基础的理性设计，强化广谱干预靶点，辅以mRNA疫苗等技术，在动物感染模型上，进行免疫原性、预防和保护效果的评估，为疾病防控提供候选疫苗。", "directions": "重要囊膜病毒的入侵机制、宿主抗体应答规律以及干预手段的设计和开发", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "一种寨卡病毒人源单克隆抗体及其应用（发明专利），授权号：ZL201610649447.0\n一种黄病毒人源单克隆抗体及应用（发明专利），授权号：ZL201611108858.5\n一种寨卡病毒特异性中和抗体及其应用（发明专利），授权号：ZL201910468377.2\n一种高中和活性的寨卡病毒人源单克隆抗体及其应用（发明专利），授权号：ZL201910468062.8\n一种裂谷热病毒人源单克隆抗体及其应用（发明专利），授权号：ZL201910116927.4\n新型冠状病毒的人源单克隆抗体及其应用（发明专利），授权号：ZL202110202604.4\n一种裂谷热病毒人源单克隆抗体及其应用（发明专利），授权号：ZL202010860411.3\n一种广谱新型冠状病毒的人源抗体及其应用（发明专利），授权号：ZL202210228772.5\n一种高效中和新型冠状病毒的人源抗体及其应用（发明专利），授权号：ZL202210296583.1", "project": null, "award": "荣获第一届中国科学院青年五四奖章，2022年\n荣获2021年度中国科学院青年科学家奖，2021年\n入选全国科技系统抗击新冠肺炎疫情先进个人，2021年\n荣获第十四届吴孟超医学青年基金奖，2021年\n荣获第十四届谈家桢生命科学创新奖，2021年\n入选中国科学院科技创新发展中心（北京分院）优秀共产党员，2020年\n获得第二届中源协和生命医学创新突破奖，2017年", "paper": "1. Han Y#, An Y#, Chen Q#, Xu K#, Liu X#, Xu S, Duan H, Vogel AB, Sahin U, Wang Q*, Dai L*, Gao GF*. mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2. Cell Res. 2022, 14:1-4.\n2. Zhao Z#, Zhou J#, Tian M#, Huang M#, Liu S#, Xie Y#, Han P, Bai C, Han P, Zheng A, Fu L, Gao Y, Peng Q, Li Y, Chai Y, Zhang Z, Zhao X, Song H*, Qi J*, Wang Q*, Wang P*, Gao GF*. Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape. Nat Commun. 2022, 13(1):4958.\n3. Huang M#, Wu L#, Zheng A#, Xie Y#, He Q#, Rong X, Han P, Du P, Han P, Zhang Z, Zhao R, Jia Y, Li L, Bai B, Hu Z, Hu S, Niu S, Hu Y, Liu H, Liu B, Cui K, Li W, Zhao X, Liu K, Qi J*, Wang Q*, Gao GF*. Atlas of currently-available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3. Immunity. 2022, 55(8):1501-1514.\n4. Du P, Gao GF, Wang Q*. The mysterious origins of the Omicron variant of SARS-CoV-2. Innovation (N Y). 2022, 3(2):100206.\n5. Zheng A#, Wu L#, Ma R#, Han P#, Huang B, Qiao C, Wang Q*, Tan W*, Gao GF*, Han P*. A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants. Signal Transduct Target Ther. 2022, 7(1):10.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202005/W020220323393676362427.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202005/t20200514_5579614.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "创新疫苗与免疫青年研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64857408", "email": "dailp@im.ac.cn", "job_title": "研究员", "abstracts": "长期从事重要病原的新型疫苗的设计与开发、以及保护性免疫应答机制研究，主要聚焦在：(1）重要病原主要抗原蛋白的结构基础；(2）基于结构的创新疫苗设计与开发；(3）保护性免疫应答机制研究；(4）推动基础研究成果向临床转化。研究组在针对新型冠状病毒、寨卡病毒等重大传染病疫苗研究与开发中取得重要研究和转化成果，其中新冠重组蛋白疫苗获包括我国在内的多国批准使用。承担了国家自然科学基金委、科技部、中国科学院等多项课题。", "directions": "重要病原的新型疫苗设计与开发、保护性免疫应答机制研究", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "1. 2023年，中国专利银奖", "project": "承担了国家自然科学基金委、科技部、中国科学院等多项课题", "award": "1. 2023年，中国专利银奖\n2. 2022年，中国科学院青年创新促进会“优秀会员”\n3. 2021年，国家自然科学基金优秀青年科学基金\n4. 2021年，（第六届）中源协和生命医学创新突破奖\n5. 2018年，中国免疫学会青年学者奖", "paper": "1. Dai L#, Duan H#, Liu X#, Zhou H#, Duan M, An Y, Yuan L, Zhao X, Xu K, Wu Q, Gao GF. Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection. Lancet. 2023 Aug 26;402(10403):687-689.\n2. Guo S#, Zheng Y#, Gao Z#, Duan M#, Liu S#, Du P, Xu X, Xu K, Zhao X, Chai Y, Wang P, Zhao Q, Gao GF*, Dai L*. Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine. Cell Discovery. 2023 Jul 28;9(1):79.\n3. Xu S#, Duan H#, An Y, Jin X, Duan M, Dubois PM, Huang Y, Xu K, Du H, Kleanthous H*, Dai L*, Gao GF*. Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE？. Vaccine. 2023 Apr 24;41(17):2793-2803.\n4. Duan M, Duan H, An Y, Zheng T, Wan S, Wang H, Zhao X, Dai L*, Xu K*, Gao GF. A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5. Emerging Microbes & Infections. 2023 Dec;12(1):e2179357.\n5. Dai L#, Gao L#, Tao L, Hadinegoro SR#, Erkin M#, Ying Z#, He P, Girsang RT, Vergara H, Akram J, Satari HI, Khaliq T, Sughra U, Celi AP, Li F, Li Y, Jiang Z, Dalimova D, Tuychiev J, Turdikulova S, Ikram A, Flores Lastra N, Ding F, Suhardono M, Fadlyana E, Yan J, Hu Z#, Li C#, Abdurakhmonov IY#, Gao GF*, ZF2001 Global Trial Group. Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults. New England Journal of Medicine. 2022 May 4. doi: 10.1056/NEJMoa2202261.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202011/W020201107577865000631.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202011/t20201107_5742014.html", "results": null, "publication": null, "personal_website": "http://www.im.cas.cn/zp2018/bshzp/202104/t20210430_6005499.html", "parent_id": null}, {"name": "肿瘤病毒与细胞免疫研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "liulongchao@im.ac.cn", "job_title": "研究员", "abstracts": null, "directions": "1. 以双特异性抗体，肿瘤疫苗等治疗手段为基础，开发肿瘤免疫治疗新策略\n2. 以单细胞分辨率绘制T细胞免疫识别-免疫耐受图谱，探索免疫治疗新靶点", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": null, "award": "2023年 入选国家级相关人才计划\n2015年 中国科学院大学三好学生\n2008年 国家奖学金", "paper": "1. Wang X,Liu L*, Yue T, Sun Z, Bae J, Tseng K, Zhang A, Qian J* and Yang-Xin Fu*. Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates dysfunctional CD8+ T cells.Signal Transduction and Targeted Therapy2023, doi:10.1038/s41392-023-01463-y.\n2. Liu L*and Chen J. Therapeutic antibodies for precise cancer immunotherapy: current and future perspectives.Medical Review2023, doi:10.1515/mr-2022-0033.\n3. Bae J#,Liu L#, Moore C#, Hsu E, Zhang A, Ren Z, et al. IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8(+) T cells to overcome immunotherapy resistance in cancer.Nat Cell Biol2022;24:1754-1765.\n4. Liu L#, Chen J#, Zhang H#, Ye J, Moore C, Lu C, et al. Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity.Nat Cancer2022;3:437-452.\n5. Liu L, Chen J, Bae J, Li H, Sun Z, Moore C, et al. Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells.Nat Biomed Eng2021;5:1261-1273.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202301/W020240424574932405277.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员，课题组长", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202301/t20230108_6597217.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "病原菌表型耐药分子机制研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "zhujh@im.ac.cn", "job_title": "研究员", "abstracts": "相较于偶发的基因组突变和水平基因转移等事件，细菌个体在表型层面的变化（Variation）乃至分化（Diversification）几乎每时每刻都在发生。细胞间的表型差异可帮助少量病原菌个体在面对宿主免疫和抗生素胁迫时维持生存、生长、乃至扩张，这些个体的生存繁衍则为病原菌的临床进化提供了关键的物质基础——基因组的复制。深入研究病原菌在复杂条件下的表型异质性（Phenotypic heterogeneity）及其底层分子机制可以帮助我们更好地理解病原菌在宿主感染及药物治疗过程中的行为模式，预测其可能的临床进化方向，寻找被忽视的药物靶点。 本研究组将结合高通量显微成像、高通量群体及单细菌测序等方法，系统性地刻画重要病原菌在不同环境下的单细菌表型和基因表达谱，追踪病原菌在宿主间传播，建立感染，耐受抗生素杀灭，抵御宿主免疫抑制等重要步骤中的表型分化过程，鉴定关键的细菌亚群及其分子基础，为临床预防、检测和治疗方案的优化提供新的技术和理论支撑。", "directions": "1. 鉴定重要病原菌表型耐药的细胞学呈现及分子机制\n2. 探索高通量分析单细菌表型及基因表达谱的新方法", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": null, "award": "2011，北京大学东宝奖学金\n2007-2011，北京大学明德奖学金\n2007，第18届国际奥林匹克生物学竞赛金牌", "paper": "1. Harim I. Won,Junhao Zhu#*, Olga Kandror, Tatos Akopian, Ian D. Wolf, Michael C. Chao, Maya Waldor, Eric J. Rubin. Chemically-induced targeted protein degradation in mycobacteria uncovers antibacterial effects and potentiates antibiotic efficacy.BioRxiv, 2023.\n2. Junhao Zhu, Yue J. Liu, Sarah M. Fortune. Spatiotemporal perspectives on tuberculosis chemotherapy.Current Opinion in Microbiology 2023, 72:102266.\n3. Qingyun Liu,Junhao Zhu#, Charles L Dulberger, Sydney Stanley, Sean Wilson, Eun Seon Chung, Xin Wang, Peter Culviner, Yue J. Liu, Nathan D. Hicks, Gregory H. Babunovic, Samantha R. Giffen, Bree B. Aldridge, Ethan C. Garner, Eric J. Rubin, Michael C. Chao, Sarah M. Fortune. Tuberculosis treatment failure associated with evolution of antibiotic resilience.Science 2022, 378(6624):1111-1118.\n4. Junhao Zhu, Ian D. Wolf, Charles L. Dulberger, Harim I. Won, Jemila C. Kester, Julius A. Judd, Samantha E. Wirth, Ryan R. Clark, Yawei Li, Yuan Luo, Todd A Gray, Joseph T Wade, Keith M Derbyshire, *Sarah M Fortune, Eric J Rubin. Spatiotemporal localization of proteins in mycobacteria.Cell Reports 2021, 37(13):110154.\n5. Biwei Wang,Junhao Zhu#, Babak Javid. Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance.Scientific Reports 2020, 21;10(1):8402.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202310/W020231225520263056549.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员，博士生导师", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202310/t20231023_6904830.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "T细胞免疫与疫苗免疫研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "zhumz@im.ac.cn", "job_title": "研究员", "abstracts": "利用疫苗、感染和肿瘤等动物模型，结合临床样本，从淋巴组织微环境（外因）和表观遗传（内因）两个角度，系统研究T细胞发育、稳态、应答和记忆等重要免疫事件的细胞和分子调控机制，揭示其生理病理意义，研发创新型疫苗和免疫干预新策略。", "directions": "T细胞的发育、稳态、应答和记忆\n淋巴组织微环境调控T细胞免疫的作用和机制\n表观遗传调控T细胞免疫的作用和机制\n疫苗免疫学", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": null, "award": "2020年 国家自然科学基金委“杰出青年科学基金”（医学免疫学）\n2020年 中国科学院大学朱李月华优秀教师奖\n2021年 药明康德生命化学研究奖“学者奖”\n2021年 2020年度中国科学十大进展\n2022年 中国科学院杰出科技成就奖（集体奖）", "paper": "1. Ren, B., Xia, H., Liao, Y., Zhou, H., Wang, Z., Shi, Y., and Zhu, M.* (2022) Endothelial SIRP signaling controls thymic progenitor homing for T cell regeneration and antitumor immunity. Elife 11:e69219\n2. Zhu, M* (2021) Immunological perspectives on spatial and temporal vaccine delivery. Advanced Drug Delivery Reviews 178, 113966\n3. Duan, H., Jing, L., Jiang, X., Ma, Y., Wang, D., Xiang, J., Chen, X., Wu, Z., Yan, H., Jia, J., Liu, Z., Feng, J., Zhu, M.*, and Yan, X.* (2021) CD146 bound to LCK promotes TCR signaling and anti-tumor immune response in mice. J Clin Invest 131, 148568\n4. Xia, H., Zhong, S., Zhao, Y., Ren, B., Wang, Z., Shi, Y., Chai, Q., Wang, X.*, and Zhu, M.* (2021) Thymic Egress Is Regulated by T Cell-Derived LT R Signal and via Distinct Thymic Portal Endothelial Cells. Frontiers in Immunology 12, 707404\n5. Wang, W., Huang, B., Zhu, Y., Tan, W.*, and Zhu, M.* (2021) Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice. Cellular & Molecular Immunology 18, 749-751", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202312/W020231225521895178891.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "研究员", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202312/t20231205_6940395.html", "results": null, "publication": null, "personal_website": "https://people.ucas.edu.cn/-zhumz", "parent_id": null}, {"name": "病毒受体与基因编辑青年研究组", "institute_id": 26, "laboratory_id": 169, "phone": "010-64807688", "email": "zhaoxin@im.ac.cn", "job_title": "项目研究员", "abstracts": "病毒的入侵是病毒感染的首要步骤，影响病毒宿主范围、跨种传播、组织嗜性等。病毒与受体的结合是病毒入侵的关键步骤，也是疫苗设计和抗病毒药物开发的重要靶点。因此病毒受体的发现和病毒-受体互作机制的解析，不仅是认识病毒感染的重要环节，更是药物和疫苗研发的基础。而病毒-宿主互作关键位点的突变，将引起病毒感染性质和免疫原性的变化。因此，研究病毒与受体相互作用机制及免疫影响，对于病毒药物疫苗的研发至关重要。研究团队一直致力于重要病毒入侵机制及抗病毒免疫的研究。通过整合病毒学、免疫学、结构生物学等研究方法，研究以肠道病毒和新冠病毒为代表的人类致病病毒。围绕着病毒的入侵步骤，发现病毒入侵关键受体，阐明病毒与受体结合及入侵机制，剖析病毒入侵中的关键氨基酸突变及其对感染和免疫的影响，并进一步进行病毒免疫逃逸和疫苗免疫策略优化研究。不仅为科学防控提供理论基础，也为药物疫苗研发和应用提供了新思路。", "directions": "1.基于CRISPR的病原受体筛选及入侵机制研究\n2.病毒入侵阻断及抗病毒免疫研究", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": null, "project": null, "award": "1.2019年 北京市科委 北京市科技新星\n2.2019年 中国医学科学院 2019年度中国医学重大进展\n3.2020年 中国科学院 青年创新促进会会员\n4.2023年 国家自然科学基金 优秀青年基金项目", "paper": "1.Chen, Xiangpeng#; Qu, Xiao#; Liu, Congcong#; Zhang, Yong; Zhang, Guigen; Han, Pu; Duan, Yali; Li, Qi; Wang, Liang; Ruan, Wenjing; Wang, Peiyi; Wei, Wensheng; Gao, George F.*; Zhao, Xin*; Xie, Zhengde*; Human FcRn Is a Two-in-One Attachment-Uncoating Receptor for Echovirus 18, mBio, 2022, e01166-22\n2.Zhao, Xin#; Zhang, Rong#; Qiao, Shitong#; Wang, Xiao; Zhang, Weibing; Ruan, Wenjing; Dai, Lianpan; Han, Pengcheng; Gao, George F.; Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines, New England Journal of Medicine, 2022, 387(3): 277-280\n3.Li, Linjie#; Liao, Hanyi#; Meng, Yumin#; Li, Weiwei#; Han, Pengcheng#; Liu, Kefang; Wang, Qing; Li, Dedong; Zhang, Yanfang; Wang, Liang; Fan, Zheng; Zhang, Yuqin; Wang, Qiyue; Zhao, Xin*; Sun, Yeping*; Huang, Niu*; Qi, Jianxun; Gao, George Fu*; Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1, Cell, 2022, 185: 1-9\n4.Zhao, Xin#; Li, Dedong#; Ruan, Wenjing#; Chen, Zhihai#; Zhang, Rong; Zheng, Anqi; Qiao, Shitong; Zheng, Xinlei; Zhao, Yingze; Dai, Lianpan; Han, Pengcheng; Gao, George F.; Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant, New England Journal of Medicine, 2022, 386(9)\n5.Zhang, Rong; Li, Dedong; Xu, Kun; Yang, Chenxi; Luo, Tingrong; Zhao, Xin*; Gao, George F; A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice, The Lancet microbe, 2022, Mar. 3(3): e165-e166", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202209/W020220906587021355656.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "项目研究员", "office_address": "北京市朝阳区北辰西路1号院3号", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202209/t20220906_6509732.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}, {"name": "肿瘤免疫与T细胞识别青年研究组", "institute_id": 26, "laboratory_id": 169, "phone": null, "email": "tansg@im.ac.cn", "job_title": "博士 项目研究员", "abstracts": "T细胞发挥效应一方面依赖于T细胞受体(TCR)介导的特异性识别，另一方面受到激活型/抑制型免疫调节受体/配体间相互作用产生的功能调节，以维持免疫应答的适度和有效。主要开展T细胞免疫识别与功能调控关键受体/配体间相互作用的分子机制研究，为理解免疫应答和免疫调节机制提供重要基础，为开发免疫治疗新策略提供关键理论支撑。T细胞是机体获得性免疫的关键组成部分，在机体保护性免疫应答中发挥了至关重要的作用，而围绕T细胞特异性识别和功能调控的免疫治疗策略在感染性疾病和肿瘤等疾病的临床治疗中具有重要的应用价值，是细胞和蛋白药物开发的重要基础。主要开展基于TCR和T细胞激活型/抑制型免疫调节受体/配体的免疫应答调控分子设计，开发以T细胞为基础的免疫治疗新策略，创新免疫治疗技术，为针对感染性疾病和肿瘤等的药物开发提供候选药物。", "directions": "1.T细胞免疫识别与功能调控分子的互作机制\n2.免疫应答调控分子设计与免疫治疗新策略", "talent_title": null, "administrative_title": null, "education_experience": null, "work_experience": null, "patent": "1. 高福，谭曙光。可用于结核分枝杆菌感染检测的表位多肽及其应用。授权号：ZL201110362902.6.\n2. 高福，谭曙光，张卫红，范盘生，张宁，万康林。一种结核诊断组合物及其应用。授权号：ZL201210090659.1\n3. 高福，严景华，谭曙光，仝舟，陈丹青，张浩，何为无，马东辉。一种抗PD-1抗体及其应用。授权号：ZL201611218724.9。\n4. 严景华，郭俐静，谭曙光，史瑞，高福。一种抗PD-L1抗体及其在抗肿瘤治疗中的应用。授权号：ZL201810952740.3 \n5. 严景华，陈丹青，谭曙光，仝舟，高福。一种PD-1特异性抗体及其抗肿瘤应用。授权号：ZL201810822534.0，\n6. 严景华，陈丹青，谭曙光，仝舟，高福。一种靶向PD-1的肿瘤抑制性抗体及其应用。授权号：ZL201810824462.3\n7. 高福，张贺琳，谭曙光，孙萌。NY-ESO-1特异性T细胞受体筛选及其抗肿瘤用途。授权号：ZL 202011213075.X\n8. 高福、孙萌、谭曙光、张贺琳、王杰。人乳头瘤病毒特异性T细胞受体及其抗肿瘤用途。授权号：ZL 202011387642      \n9. 严景华，史瑞，谭曙光，马素芳，高福。一种抗CD47抗体及其应用。授权号：ZL 201810816866.8\n10. 刘磊，刘映霞，沈晨光，吴燕，谭曙光，李德林，王菲然，高福。一种抗新型冠状病毒的单克隆抗体及其应用。授权号：ZL 202010151350.3\n11. 刘磊，刘映霞，沈晨光，吴燕，谭曙光，李德林，王菲然，高福。一种抗新型冠状病毒的单克隆抗体及其应用。授权号：ZL 202010151348.6\n12. 高福，吴燕，李世华，黎朝晖，谭曙光。一种抗新型冠状病毒的双特异性抗体。申请号： 202010763140.X\n13. 高福，谭曙光，卢丹。KRAS突变特异性T细胞受体筛选及抗肿瘤用途。申请号： 202011047695.0  \n14. 高福，谭曙光，孙文桥，蒋敏。结核诊断细胞因子及其应用。申请号：202110769128.4。\n15. 高福，谭曙光，蒋敏，孙文桥。结核鉴别诊断细胞因子及其在结核感染风险评估中的应用。申请号：202110768774.9\n16. 高福，蒋敏，谭曙光，孙文桥。WT1抗原特异性T细胞受体及其抗肿瘤用途。申请号：202210435441.9", "project": "1.T细胞免疫识别与功能调控关键受体/配体间相互作用的分子机制研究\n2.基于TCR和T细胞激活型/抑制型免疫调节受体/配体的免疫应答调控分子设计，开发以T细胞为基础的免疫治疗新策略", "award": "2017年 获第七届中国免疫学会青年学者奖\n2022年 获国家自然科学基金优秀青年基金", "paper": "1.Li, Z.#, Li, S#, Zhang G#, Peng W#, Chang Z, Zhang X, Fan Z, Chai Y, Wang F, Zhao X, Li D, Zhang R, He Z, Xu K, Lei W, Liu P, Hao J, Zhang J, Sun L, Wu G, Tan S*, Gao GF*, Gao F*, Wu Y*. An engineered bispecific human monoclonal antibody against SARS-CoV-2. Nature Immunology. 2022 Mar;23(3):423-430\n2.Sun M, Zhang H, Chai Y, Jiang M, Qi J, Gao G.F.*, Tan S*. Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2. iScience. 2021. Sep 30;24(10):103190.\n3.Zhao M#, Fu L#, Chai Y, Sun M, Li Y, Wang S, Qi J, Zeng B, Kang L, Gao G.F.*, Tan S*. Atypical TNF-TNFR superfamily binding interface in GITR-GITRL complex for T cell activation. Cell Reports 2021. 36, 109734.\n4.Zhang H, Sun M, Wang J, Zeng B, Cao X, Han Y, Tan S* and Gao GF*. Identification of NY-ESO-1157-165specific murine T cell receptors with distinct recognition patterns for tumor immunotherapy. Frontiers in Immunology. 2021. Mar 23;12:644520.\n5.Liu K#, Tan S#, Niu S#, Wang J#,Wu L, Sun H, Zhang Y, Pan X, Qu X, Du P, Meng Y, Jia Y, Chen Q, Deng C, Yan J, Wang H, Wang Q*, Qi J*, Gao GF*. Cross-species recognition of SARS-CoV-2 to bat ACE2. Proceedings of the National Academy of Sciences of the United States of America. 2021 Jan 5;118(1):e2020216118.", "social_job": null, "picture": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202209/W020220906598071899600.jpg", "education": "研究生", "qualification": "博士", "job_information": 1, "responsibilities": "项目研究员", "office_address": "北京市朝阳区北辰西路1号院3号F315室", "origin": "http://www.im.cas.cn/jgsz2018/yjtx/zgkxybywswymyxzdsys/202209/t20220906_6509757.html", "results": null, "publication": null, "personal_website": null, "parent_id": null}]